Verocytotoxin-induced apoptosis of human microvascular endothelial cells.

The pathogenesis of the epidemic form of hemolytic uremic syndrome is characterized by endothelial cell damage. In this study, the role of apoptosis in verocytotoxin (VT)-mediated endothelial cell death in human glomerular microvascular endothelial cells (GMVEC), human umbilical vein endothelial cells, and foreskin microvascular endothelial cells (FMVEC) was investigated. VT induced apoptosis in GMVEC and human umbilical vein endothelial cells when the cells were prestimulated with the inflammatory mediator tumor necrosis factor-alpha (TNF-alpha). FMVEC displayed strong binding of VT and high susceptibility to VT under basal conditions, which made them suitable for the study of VT-induced apoptosis without TNF-alpha interference. On the basis of functional (flow cytometry and immunofluorescence microscopy using FITC-conjugated annexin V and propidium iodide), morphologic (transmission electron microscopy), and molecular (agarose gel electrophoresis of cellular DNA fragments) criteria, it was documented that VT induced programmed cell death in microvascular endothelial cells in a dose- and time-dependent manner. Furthermore, whereas partial inhibition of protein synthesis by VT was associated with a considerable number of apoptotic cells, comparable inhibition of protein synthesis by cycloheximide was not. This suggests that additional pathways, independent of protein synthesis inhibition, may be involved in VT-mediated apoptosis in microvascular endothelial cells. Specific inhibition of caspases by Ac-Asp-Glu-Val-Asp-CHO, but not by Ac-Tyr-Val-Ala-Asp-CHO, was accompanied by inhibition of VT-induced apoptosis in FMVEC and TNF-alpha-treated GMVEC. These data indicate that VT can induce apoptosis in human microvascular endothelial cells.

[1]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[2]  K. Elkon.  Caspases , 1999, The Journal of Experimental Medicine.

[3]  B. McManus,et al.  Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. , 1999, The American journal of pathology.

[4]  S. Izumo,et al.  Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.

[5]  H. Uchida,et al.  Verotoxins induce apoptosis in human renal tubular epithelium derived cells. , 1998, Kidney international.

[6]  S. Yonehara,et al.  Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis , 1998, The Journal of experimental medicine.

[7]  A. Caprioli,et al.  Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies , 1998, Infection and Immunity.

[8]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[9]  A. Melton-Celsa.  Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals , 1998 .

[10]  V. V. van Hinsbergh,et al.  Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. , 1997, Journal of the American Society of Nephrology : JASN.

[11]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[12]  D. Milford,et al.  Comparison of ribosome-inactivating proteins in the induction of apoptosis. , 1997, Toxicology letters.

[13]  R. Gascoyne,et al.  Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. , 1997, Cancer research.

[14]  V. V. van Hinsbergh,et al.  Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells , 1997 .

[15]  A. Zeiher,et al.  Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. , 1997, Circulation.

[16]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[17]  E. Jaffe,et al.  Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. , 1997, Blood.

[18]  C. S. Lin,et al.  TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation. , 1997, Journal of immunology.

[19]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.

[20]  G. Barnett,et al.  Involvement of interleukin‐1β‐converting enzyme in apoptosis of bFGF‐deprived murine aortic endothelial cells , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Karsan,et al.  Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. , 1996, Blood.

[22]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[23]  D. Milford,et al.  Verocytotoxin-1 induces apoptosis in vero cells. , 1995, The Journal of infection.

[24]  V. V. van Hinsbergh,et al.  Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. , 1994, Blood.

[25]  M. Peterson,et al.  Induction of Endothelial Cell Apoptosis by TNFα: Modulation by Inhibitors of Protein Synthesis , 1994 .

[26]  Y. Hannun,et al.  Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. , 1993, Biochimica et biophysica acta.

[27]  B. Caillou,et al.  Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. , 1993, Cancer research.

[28]  R. Collier,et al.  DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. , 1993, Experimental cell research.

[29]  V. V. van Hinsbergh,et al.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. , 1992, Blood.

[30]  D. Green,et al.  Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.

[31]  B. Bonavida,et al.  Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. , 1992, Journal of immunology.

[32]  B. Deurs,et al.  Toxin-induced cell lysis: protection by 3-methyladenine and cycloheximide. , 1992, Experimental cell research.

[33]  W. Fiers,et al.  Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. , 1991, The American journal of pathology.

[34]  B. Bonavida,et al.  Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition. , 1989, The Journal of biological chemistry.

[35]  L. Becker,et al.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.

[36]  T. Yutsudo,et al.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.

[37]  A. Howat,et al.  The toxic plant proteins ricin and abrin induce apoptotic changes in mammalian lymphoid tissues and intestine. , 1988, Journal of Pathology.

[38]  C. Lingwood,et al.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.

[39]  A. Wyllie,et al.  Death and the cell. , 1986, Immunology today.

[40]  B. Zetter,et al.  Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.

[41]  J. S. Fong,et al.  Hemolytic-Uremic Syndrome: Current Concepts and Management , 1982 .

[42]  K. Bensch,et al.  Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. , 1980, The Journal of investigative dermatology.

[43]  A. Wyllie.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[44]  T. Maciag,et al.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Tiddens,et al.  Haemolytic uraemic syndrome. , 1979, Paediatrician.

[46]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.